Literature DB >> 2345296

Colonial morphology of staphylococci on Memphis agar: phase variation of slime production, resistance to beta-lactam antibiotics, and virulence.

G D Christensen1, L M Baddour, B M Madison, J T Parisi, S N Abraham, D L Hasty, J H Lowrance, J A Josephs, W A Simpson.   

Abstract

The growth of Staphylococcus epidermidis sensu stricto and Staphylococcus saprophyticus on Memphis agar yielded up to 6 morphotypes with each strain. With S. epidermidis, one morphotype produced slime (rho) but became non-slime-producing (epsilon) at a high frequency. The slime-producing rho variants were methicillin-resistant and more virulent than methicillin-susceptible epsilon variants in an endocarditis model. With S. saprophyticus, phase variation was of higher frequency. Nitrosoguanidine mutagenesis produced a stable blue epsilon form that was more virulent than the parent in a mouse model of urinary tract infection. Mutants with the blue epsilon phenotype differed from gold epsilon parents in a variety of phenotypic properties, including increased resistance to oxacillin. These staphylococcal species have a high frequency of phase variation: Phase variants differ in antibiotic resistance and virulence, which is only partially correlated with suggested virulence factors such as slime production.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2345296     DOI: 10.1093/infdis/161.6.1153

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  42 in total

1.  PCR-Based assay for discrimination between invasive and contaminating Staphylococcus epidermidis strains.

Authors:  N B Frebourg; S Lefebvre; S Baert; J F Lemeland
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Phenotypic variation of Staphylococcus epidermidis isolated from a patient with native valve endocarditis.

Authors:  M Deighton; S Pearson; J Capstick; D Spelman; R Borland
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

3.  Phase variations in Bifidobacterium animalis.

Authors:  B Biavati; F Crociani; P Mattarelli; V Scardovi
Journal:  Curr Microbiol       Date:  1992-07       Impact factor: 2.188

4.  Differential production of slime under aerobic and anaerobic conditions.

Authors:  L P Barker; W A Simpson; G D Christensen
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

5.  In vitro measurement of the adherence of Staphylococcus epidermidis to plastic by using cellular urease as a marker.

Authors:  W M Dunne; E M Burd
Journal:  Appl Environ Microbiol       Date:  1991-03       Impact factor: 4.792

6.  Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model.

Authors:  Steven L Percival; Phillip G Bowler; Jayne Dolman
Journal:  Int Wound J       Date:  2007-06       Impact factor: 3.315

7.  Differential expression of methicillin resistance by different biofilm-negative Staphylococcus epidermidis transposon mutant classes.

Authors:  Dietrich Mack; Axel Sabottke; Sabine Dobinsky; Holger Rohde; Matthias A Horstkotte; Johannes K-M Knobloch
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

8.  Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin.

Authors:  D Mack; M Nedelmann; A Krokotsch; A Schwarzkopf; J Heesemann; R Laufs
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Phase variation of slime production in Staphylococcus aureus: implications in colonization and virulence.

Authors:  R Baselga; I Albizu; M De La Cruz; E Del Cacho; M Barberan; B Amorena
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Staphylococcus epidermidis saeR is an effector of anaerobic growth and a mediator of acute inflammation.

Authors:  L D Handke; K L Rogers; M E Olson; G A Somerville; T J Jerrells; M E Rupp; P M Dunman; P D Fey
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.